PCV108 - Medication Adherence and Risk of Hospitalization in Pulmonary Arterial Hypertension (PAH) Patients Treated with Endothelin Receptor Antagonists (ERAS) or Phosphodiesterase Type 5 Inhibitors (PDE5IS)

Autor: Hill, JW, Lickert, CB, Cole, MR, Wade, RL, Tsang, Y, Drake, W
Zdroj: In Value in Health October-November 2017 20(9):A620-A620
Databáze: ScienceDirect